NYSE:USNA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products.


Snowflake Analysis

Flawless balance sheet and fair value.


Similar Companies

Share Price & News

How has USANA Health Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: USNA has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

2.9%

USNA

3.0%

US Personal Products

1.5%

US Market


1 Year Return

40.5%

USNA

-4.8%

US Personal Products

6.9%

US Market

Return vs Industry: USNA exceeded the US Personal Products industry which returned -6.2% over the past year.

Return vs Market: USNA exceeded the US Market which returned 5.3% over the past year.


Shareholder returns

USNAIndustryMarket
7 Day2.9%3.0%1.5%
30 Day5.2%2.9%5.9%
90 Day24.2%22.7%17.9%
1 Year40.5%40.5%-3.7%-4.8%9.2%6.9%
3 Year33.0%33.0%43.0%36.1%36.4%27.5%
5 Year33.0%33.0%39.3%27.9%64.9%47.0%

Price Volatility Vs. Market

How volatile is USANA Health Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is USANA Health Sciences undervalued compared to its fair value and its price relative to the market?

39.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: USNA ($85) is trading below our estimate of fair value ($140.4)

Significantly Below Fair Value: USNA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: USNA is good value based on its PE Ratio (18.3x) compared to the US Personal Products industry average (19.8x).

PE vs Market: USNA is poor value based on its PE Ratio (18.3x) compared to the US market (16.1x).


Price to Earnings Growth Ratio

PEG Ratio: USNA is poor value based on its PEG Ratio (4.9x)


Price to Book Ratio

PB vs Industry: USNA is overvalued based on its PB Ratio (5.6x) compared to the US Personal Products industry average (2.7x).


Next Steps

Future Growth

How is USANA Health Sciences forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

3.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: USNA's forecast earnings growth (3.7% per year) is above the savings rate (2.2%).

Earnings vs Market: USNA's earnings (3.7% per year) are forecast to grow slower than the US market (22.5% per year).

High Growth Earnings: USNA's earnings are forecast to grow, but not significantly.

Revenue vs Market: USNA's revenue (3.5% per year) is forecast to grow slower than the US market (9.2% per year).

High Growth Revenue: USNA's revenue (3.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if USNA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has USANA Health Sciences performed over the past 5 years?

3.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: USNA has high quality earnings.

Growing Profit Margin: USNA's current net profit margins (9.8%) are lower than last year (10.4%).


Past Earnings Growth Analysis

Earnings Trend: USNA's earnings have grown by 3.4% per year over the past 5 years.

Accelerating Growth: USNA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: USNA had negative earnings growth (-15.3%) over the past year, making it difficult to compare to the Personal Products industry average (17.5%).


Return on Equity

High ROE: USNA's Return on Equity (32.4%) is considered high.


Next Steps

Financial Health

How is USANA Health Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: USNA's short term assets ($286.8M) exceed its short term liabilities ($124.5M).

Long Term Liabilities: USNA's short term assets ($286.8M) exceed its long term liabilities ($31.6M).


Debt to Equity History and Analysis

Debt Level: USNA is debt free.

Reducing Debt: USNA had no debt 5 years ago.

Debt Coverage: USNA has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: USNA has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is USANA Health Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate USNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate USNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if USNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if USNA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of USNA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Kevin Guest (57yo)

3.67yrs

Tenure

US$4,157,827

Compensation

Mr. Kevin G. Guest serves as Chairman of the Board of USANA Health Sciences, Inc. since May 1, 2020. Mr. Guest has been the Chief Executive Officer of USANA Health Sciences, Inc. since November 23, 2016. M ...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD4.16M) is about average for companies of similar size in the US market ($USD4.72M).

Compensation vs Earnings: Kevin's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Guest
Chairman of the Board & CEO3.67yrsUS$4.16m0.014% $247.4k
Jim Brown
President3.67yrsUS$2.09m0.049% $867.4k
G. Hekking
Chief Financial Officer3.17yrsUS$1.47m0.0091% $162.5k
Walter Noot
Chief Operating Officer0.75yrUS$1.37mno data
David Mulham
Chief Sales Officerno dataUS$1.39m0.042% $751.3k
Myron Wentz
Founder & Chairman Emeritus0.17yrno data43.24% $772.3m
John Cuomo
Executive Director of Product Development & Technology7.58yrsno datano data
Robert Sinnott
Chief Scientific Officer3.92yrsno datano data
Patrique Richards
Executive Director of Investor Relations & Business Developmentno datano datano data
P. Foukas
Chief Legal Officer2yrsno datano data
Daniel Macuga
Chief Communications & Marketing Officer8.58yrsUS$946.07k0.0074% $132.0k
Ashley Collins
Vice President of Marketing & Public Relations3.58yrsno datano data

3.7yrs

Average Tenure

54yo

Average Age

Experienced Management: USNA's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin Guest
Chairman of the Board & CEO3.67yrsUS$4.16m0.014% $247.4k
Myron Wentz
Founder & Chairman Emeritus0.17yrno data43.24% $772.3m
Gilbert Fuller
Lead Independent Directorno dataUS$228.20kno data
Peggie Pelosi
Independent Director1.58yrsUS$228.44k0.0041% $72.5k
Robert Anciaux
Director24yrsUS$220.60k0.0033% $58.8k
Timothy Wood
Independent Director0.75yrUS$17.60kno data
Christine Wood
Member of Scientific Advisory Councilno datano datano data
Monica Lewis
Member of Scientific Advisory Councilno datano datano data
Peter Rugg
Chairperson of Scientific Advisory Council16.5yrsno datano data
Bart Moore
Member of Scientific Advisory Councilno datano datano data
Heather Tick
Member of Scientific Advisory Councilno datano datano data
Frederic Winssinger
Independent Director4.17yrsUS$214.87k0.0024% $42.5k

1.6yrs

Average Tenure

71yo

Average Age

Experienced Board: USNA's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: USNA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

USANA Health Sciences, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: USANA Health Sciences, Inc.
  • Ticker: USNA
  • Exchange: NYSE
  • Founded: 1992
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$1.786b
  • Shares outstanding: 21.01m
  • Website: https://www.usana.com

Number of Employees


Location

  • USANA Health Sciences, Inc.
  • 3838 West Parkway Boulevard
  • Salt Lake City
  • Utah
  • 84120
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
USNANYSE (New York Stock Exchange)YesCommon StockUSUSDNov 1994
USJDB (Deutsche Boerse AG)YesCommon StockDEEURNov 1994

Biography

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/15 00:05
End of Day Share Price2020/07/14 00:00
Earnings2020/03/28
Annual Earnings2019/12/28


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.